Cargando…

Sensitivity to change and prediction of global change for the Alzheimer’s Questionnaire

INTRODUCTION: Longitudinal assessment of cognitive decline in amnestic mild cognitive impairment (aMCI) and Alzheimer’s disease (AD) often involves the use of both informant-based and objective cognitive assessments. As efforts have focused on identifying individuals in pre-clinical stages, instrume...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malek-Ahmadi, Michael, Chen, Kewei, Davis, Kathryn, Belden, Christine M, Powell, Jessica, Jacobson, Sandra A, Sabbagh, Marwan N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652427/ https://www.ncbi.nlm.nih.gov/pubmed/26584966 http://dx.doi.org/10.1186/s13195-014-0092-z

Ejemplares similares

Informant-reported cognitive symptoms that predict amnestic mild cognitive impairment
por: Malek-Ahmadi, Michael, et al.
Publicado: (2012)

Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
por: Decourt, Boris, et al.
Publicado: (2013)

The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease
por: Sabbagh, Marwan N, et al.
Publicado: (2013)

Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer’s Disease
por: Hunter, Jesse M., et al.
Publicado: (2012)

Cerebral blood flow in Alzheimer’s disease
por: Roher, Alex E, et al.
Publicado: (2012)

KIF6 719Arg Carrier Status Association with Homocysteine and C-Reactive Protein in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Patients
por: Malek-Ahmadi, Michael, et al.
Publicado: (2013)

Differences in Cerebrospinal Fluid Biomarkers between Clinically Diagnosed Idiopathic Normal Pressure Hydrocephalus and Alzheimer’s Disease
por: Tsai, Andrew, et al.
Publicado: (2014)

Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment
por: Dugger, Brittany N., et al.
Publicado: (2015)

Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition
por: Filon, Jessica R., et al.
Publicado: (2016)

Essential Tremor in the Elderly and Risk for Dementia
por: Shill, Holly A., et al.
Publicado: (2014)

Investigational drugs for the treatment of AD: what can we learn from negative trials?
por: Jacobson, Sandra A, et al.
Publicado: (2011)

Recent Perspectives on APP, Secretases, Endosomal Pathways and How they Influence Alzheimer’s Related Pathological Changes in Down Syndrome
por: DeCourt, Boris, et al.
Publicado: (2013)

Converging mediators from immune and trophic pathways to identify Parkinson disease dementia
por: Lue, Lih-Fen, et al.
Publicado: (2016)

Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts
por: Lue, Lih-Fen, et al.
Publicado: (2017)

Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson’s Disease Cases Lacking Alzheimer’s Disease Pathology
por: Maarouf, Chera L., et al.
Publicado: (2013)

Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease
por: Malek-Ahmadi, Michael, et al.
Publicado: (2019)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

New Acetylcholinesterase Inhibitors for Alzheimer's Disease
por: Mehta, Mona, et al.
Publicado: (2012)

Editorial Introduction to the Special Issue from the International Symposium on Biomarkers for Alzheimer’s Disease and Related Disorders
por: Sabbagh, Marwan N.
Publicado: (2017)

Broader Considerations of Higher Doses of Donepezil in the Treatment of Mild, Moderate, and Severe Alzheimer's Disease
por: Berk, Camryn, et al.
Publicado: (2012)

Prediction of Alzheimer's Pathological Changes in Subjective Cognitive Decline Using the Self-report Questionnaire and Neuroimaging Biomarkers
por: Hong, Yun Jeong, et al.
Publicado: (2019)

Cognitive composite score association with Alzheimer’s disease plaque and tangle pathology
por: Malek-Ahmadi, Michael, et al.
Publicado: (2018)

Novel Therapeutics in Alzheimer's Disease
por: Sabbagh, Marwan, et al.
Publicado: (2012)

Editorial: A Time of Transition of Alzheimer's Disease in the Advent of Anti-Amyloid Monoclonal Antibodies
por: Tousi, Babak, et al.
Publicado: (2021)

Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology
por: Sabbagh, Marwan, et al.
Publicado: (2011)

Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort
por: Malek-Ahmadi, Michael, et al.
Publicado: (2013)

Alzheimer’s disease beyond amyloid: strategies for future therapeutic interventions
por: Shi, Jiong, et al.
Publicado: (2020)

Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia?
por: Crum, Jana, et al.
Publicado: (2018)

Potential Peripheral Biomarkers for the Diagnosis of Alzheimer's Disease
por: Patel, Seema, et al.
Publicado: (2011)

5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
por: Andrews, Megan, et al.
Publicado: (2018)

The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference
por: Masoli, Matthew, et al.
Publicado: (2021)

Alzheimer's disease drug development pipeline: 2019
por: Cummings, Jeffrey, et al.
Publicado: (2019)

Alzheimer's disease drug development pipeline: 2020
por: Cummings, Jeffrey, et al.
Publicado: (2020)

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease?
por: Lue, Lih-Fen, et al.
Publicado: (2012)

Static and Dynamic Cognitive Reserve Proxy Measures: Interactions with Alzheimer’s Disease Neuropathology and Cognition
por: Malek-Ahmadi, Michael, et al.
Publicado: (2017)

Angioedema quality of life questionnaire (AE-QoL) - interpretability and sensitivity to change
por: Kulthanan, Kanokvalai, et al.
Publicado: (2019)

FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry”
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Global climate change: predicting the weather.
por: Manuel, J
Publicado: (1994)

Reprowebs: a conceptual approach to elasticity and change in the global assisted reproduction industry
por: König, Anika, et al.
Publicado: (2021)

Polygenic resilience score may be sensitive to preclinical Alzheimer’s disease changes
por: Eissman, Jaclyn M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k33mp0nnh0mjhpo3er2eockeb3